Tag Archives: Merck

Merck invests EUR 90 million in four sites in Germany, Switzerland and France

Relocations to drive focus on sites in Darmstadt, Schnelldorf (Germany), Buchs (Switzerland) and Molsheim (France) Sequential implementation until the end of 2022 € 90 million investment. Net impact of approximately minus 200 positions over 5 years DARMSTADT, 13-Jul-2017 — /EuropaWire/ … Read the full press release

World MS Day 2017: Merck launches multiple sclerosis (MS) care partner survey with IACO

Preliminary research indicates most MS carers are between the ages of 18-34, the prime of their lives Largest global MS carer survey with International Alliance of Carer Organizations (IACO) to help identify unmet needs and social impact Darmstadt, Germany, 31-May-2017 … Read the full press release

Merck presented new data on efficacy and safety for investigational Cladribine Tablets at the American Academy of Neurology (AAN)

Subgroup analysis shows >80% reduction in the risk of disability progression with Cladribine Tablets vs placebo DARMSTADT, 02-May-2017 — /EuropaWire/ — Merck, a leading science and technology company, announced the presentation of new analyses of efficacy and safety data for … Read the full press release

Merck: Results of the ADDRESS II Phase IIb multicenter study on atacicept in patients with systemic lupus erythematosus

Data presented at the 2016 American College of Rheumatology/Association of Rheumatology Health Professionals (ACR/ARHP) Annual Meeting (Abstract Number: 12L) DARMSTADT, 15-Nov-2016 — /EuropaWire/ — Merck, a leading science and technology company, today announced the results of the ADDRESS II Phase IIb, … Read the full press release

Ovarian Cancer: Merck, Pfizer initiate Phase III study JAVELIN Ovarian 100

First Phase III trial evaluating the addition of an immune checkpoint inhibitor to standard of care in first-line ovarian cancer New investigational regimen will evaluate avelumab in extending progression-free survival in treatment-naïve women Darmstadt, Germany and New York, US, 07-Jul-2016 … Read the full press release

Merck to support the advancement of medical science in the field of fertility through the Grant for Fertility Innovation (GFI) program

Investment reflects company’s commitment to innovation in fertility research Globally, six projects receive funding from this grant cycle Darmstadt, Germany, 07-Jul-2016 — /EuropaWire/ — Merck, a leading science and technology company, today announced it would continue to support the advancement of … Read the full press release

Merck receives global marketing and commercialization rights for Progyny’s Early Embryo Viability Assessment (Eeva®) software

Merck obtains global marketing and commercialization rights for the innovative Progyny Eeva® software offering, aiming to provide customers worldwide with innovative fertility technologies solutions This new agreement builds on the successful relationship between both leaders in fertility technologies, first established … Read the full press release

Merck CEO and Chairman of the Executive Board honoured with Weizmann Award in the Sciences and Humanities

Darmstadt, Germany, and Rehovot, Israel, 18-Feb-2016 — /EuropaWire/ — Merck, a leading science and technology company, announced that the Weizmann Institute, Rehovot, Israel, conferred the renowned Weizmann Award in the Sciences and Humanities on Karl-Ludwig Kley, CEO and Chairman of the … Read the full press release

Merck extends partnership with Weizmann Institute of Science on research collaboration

Darmstadt, Germany, and Rehovot, Israel, 18-Feb-2016 — /EuropaWire/ — Merck, a leading science and technology company, today extended the partnership with Weizmann Institute of Science, Rehovot, Israel, of by signing a new framework agreement, building on a successful innovation partnership of … Read the full press release

Merck’s acquisition of Sigma-Aldrich approved by the European Commission under EU Merger Regulation

BRUSSELS, 18-6-2015 — /EuropaWire/ — The European Commission has approved the proposed acquisition of Sigma-Aldrich by Merck under the EU Merger Regulation. Both companies are active world-wide in the life science sector. The decision is conditional on the divestment of … Read the full press release

Merck clarifies that it will keep its consumer health business

• Darmstadt-based company holds global rights to the name Merck with exception of the U.S. and Canada Darmstadt, Germany,  7-5-2014 — /EuropaWire/ — Merck, the supplier of top-quality high-tech products in the pharmaceuticals and chemicals sectors, today clarified that it will … Read the full press release

Merck announced the enrollment of first patient into new Phase III study in the area of fertility

• The ESPART* Phase III clinical study focuses on patients that respond poorly to attempts at ovarian stimulation • Study aims to recruit 946 patients across 17 European countries Darmstadt, Germany, 28-3-2014 — /EuropaWire/ — Merck, the global pharmaceutical and chemical company, … Read the full press release